Polymorphism in XRCC1 gene modulates survival and clinical outcomes of advanced North Indian lung cancer patients treated with platinum-based doublet chemotherapy.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- March 22, 2017
published in
has subject area
- Antineoplastic Combined Chemotherapy Protocols
- Camptothecin
- Carboplatin
- Cisplatin
- DNA-Binding Proteins
- Docetaxel
- Female
- Humans
- Irinotecan
- Lung Neoplasms
- Male
- Middle Aged
- Neoplasm Staging
- Pemetrexed
- Polymorphism, Single Nucleotide
- Survival Rate
- Taxoids
- Treatment Outcome
- X-ray Repair Cross Complementing Protein 1